Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
PR Sosnay, KR Siklosi, F Van Goor, K Kaniecki, H Yu… - Nature …, 2013 - nature.com
Allelic heterogeneity in disease-causing genes presents a substantial challenge to the
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
[PDF][PDF] Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
N Genet - Nat Genet, 2013 - scholar.archive.org
Allelic heterogeneity in disease-causing genes presents a substantial challenge to the
translation of genomic variation to clinical practice. Few of the almost 2,000 variants in the …
translation of genomic variation to clinical practice. Few of the almost 2,000 variants in the …
[PDF][PDF] Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
N Genet - Nat Genet, 2013 - academia.edu
Allelic heterogeneity in disease-causing genes presents a substantial challenge to the
translation of genomic variation to clinical practice. Few of the almost 2,000 variants in the …
translation of genomic variation to clinical practice. Few of the almost 2,000 variants in the …
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
PR Sosnay, KR Siklosi, F Van Goor… - Nature …, 2013 - utsouthwestern.elsevierpure.com
Allelic heterogeneity in disease-causing genes presents a substantial challenge to the
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
PR Sosnay, KR Siklosi, F Van Goor, K Kaniecki… - Nature …, 2013 - go.gale.com
Allelic heterogeneity in disease-causing genes presents a substantial challenge to the
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
PR Sosnay, KR Siklosi, F Van Goor, K Kaniecki… - Nature …, 2013 - repositorio.insa.pt
Allelic heterogeneity in disease-causing genes presents a substantial challenge to the
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
[引用][C] Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
PR Sosnay, KR Siklosi, F Van Goor, K Kaniecki, H Yu… - Nature Genetics, 2013 - cir.nii.ac.jp
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance
regulator gene | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
regulator gene | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene.
PR Sosnay, KR Siklosi, F Van Goor, K Kaniecki… - Nature …, 2013 - europepmc.org
Allelic heterogeneity in disease-causing genes presents a substantial challenge to the
translation of genomic variation to clinical practice. Few of the almost 2,000 variants in the …
translation of genomic variation to clinical practice. Few of the almost 2,000 variants in the …
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
PR Sosnay, KR Siklosi, F Van Goor… - Nature …, 2013 - pubmed.ncbi.nlm.nih.gov
Allelic heterogeneity in disease-causing genes presents a substantial challenge to the
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
PR Sosnay, KR Siklosi, F Van Goor… - Nature …, 2013 - pure.johnshopkins.edu
Allelic heterogeneity in disease-causing genes presents a substantial challenge to the
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …
translation of genomic variation into clinical practice. Few of the almost 2,000 variants in the …